Almonty Industries is sending shareholders a message that goes beyond the usual tungsten supply-chain narrative: the company believes its own equity is worth buying back. A new repurchase program authorizes up to 14.4 million shares over 36 months, capped at $300 million, running from August 24, 2026 through August 24, 2029.
The timing is hardly accidental. It arrives just as the South Korean Sangdong mine transitions from construction project to operating asset, with roughly 139,700 tonnes of ore now stockpiled at an average grade of about 0.25 percent tungsten trioxide (WO₃). That inventory buffer means the processing plant can be fed continuously while it works through its commissioning phase — a practical detail that matters more to the investment case than any single contract headline.
From Paper to Plant
The mill began throughput operations in June, pushing stockpiled material through the newly commissioned facility to produce saleable concentrate. For a company that has only recently started generating revenue from tungsten concentrate, the scale of the buyback signals management’s confidence in the balance sheet and cash-flow trajectory going forward.
That operational maturity is now the core of the story. Investors have spent much of the past year digesting contract news and analyst coverage; the focus is shifting toward whether Almonty can reliably convert its ore inventory into delivered volumes.
The commercial framework for that conversion was strengthened roughly three weeks ago, when the offtake agreement between the Almonty-controlled Sangdong mine and GTP was extended to 21 years. Total contract volume rose 40 percent to 4.41 million mtu, with guaranteed minimum offtake of 210,000 mtu annually. Since that extension was announced, the stock has gained 16.3 percent — evidence of how heavily the market weights long-term offtake security in the tungsten sector.
That contractual backbone also supports the buyback decision. A producer with two decades of committed minimum volumes can plan capital flows with far more certainty than one dependent on spot markets.
Should investors sell immediately? Or is it worth buying Almonty?
A Stock Still Finding Its Level
The share price closed Friday at EUR 15.17, down 1.2 percent on the day. The monthly picture is brighter: a 31 percent gain over the past 30 days, though the weekly figure shows a 2.6 percent pullback. Since the start of the year, the stock has risen 91 percent.
The recent price action tells a more nuanced story. Jefferies initiated coverage last Wednesday with a buy rating and a $26.25 price target, yet the shares have moved only 0.6 percent lower since — a muted response that suggests much of the good news may already be priced in.
Trading remains characteristically turbulent. The annualized 30-day volatility stands at 87 percent, a level that reflects the market’s ongoing reassessment of how quickly Sangdong’s stockpile translates into revenue. In such an environment, a buyback program can also serve as a stabilizing instrument, cushioning sharp swings.
The stock currently sits about 26 percent below its 52-week high of EUR 20.61, reached in April. Against the 52-week low of EUR 3.50 from September last year, however, the shares have more than quadrupled. That extraordinary range underscores how dramatically Almonty has been revalued over the past year, driven by the growing strategic importance of Western tungsten supply outside Chinese supply chains.
What Moves the Stock Next
For investors, the near-term question is straightforward: can Almonty process its accumulated ore stockpile quickly enough to meet the minimum delivery commitments under the GTP contract? The answer, more than any single news item, is likely to determine the share price over the coming months.
The buyback adds a layer of management conviction to that equation. The parallel delisting process at the Australian exchange carries no immediate operational significance for Nasdaq-level trading. The 87 percent volatility reading suggests the market remains on edge — but a company willing to commit $300 million to its own shares while ramping up a new processing facility is placing a substantial bet on its own execution.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from September 7 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 7.
Almonty: Buy or sell? Read more here...









